Work Here?
Industries
Food & Agriculture
Biotechnology
Company Size
51-200
Company Stage
Late Stage VC
Total Funding
$100M
Headquarters
Seacliff, California
Founded
2019
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$100M
Above
Industry Average
Funded Over
1 Rounds
Remote Work Options
APTOS, Calif., Dec. 20, 2024 /PRNewswire/ -- Ohalo Genetics, Inc. has entered into a groundbreaking Development & Commercialization Agreement with the University of Florida's Institute of Food and Agricultural Sciences, Florida Foundation Seed Producers, Inc., and the Florida Strawberry Growers Association (FSGA) to address the significant threat of neopestalotiopsis to the strawberry industry.This fungal disease, which can wipe out entire strawberry fields, has become one of the most damaging issues faced by Florida strawberry growers, affecting crop yields, increasing production costs and threatening the livelihood of farmers in a state known as the "Winter Strawberry Capital of the United States".Neopestalotiopsis was first detected in Florida in 2017, with notable outbreaks in subsequent years. By 2019 and 2020, the disease had become widespread and severely damaged the crop across the state.Currently, there are no commercially available public strawberry varieties resistant to neopestalotiopsis. Growers have relied on fungicides and rigorous field management practices to mitigate the disease's effects, but these methods come with increased costs and limited effectiveness.In response to this challenge, Ohalo® leveraged its advanced breeding technology platform with genetic resources from UF/IFAS to develop a novel trait that makes a strawberry plant resistant to neopestalotiopsis and integrated that trait into existing University of Florida strawberry varieties. These new, resistant varieties will enter non-commercial, experimental trials in 2025."This collaboration showcases the power of public-private partnerships in solving critical agricultural challenges," said Jud Ward, CTO of Ohalo
It’s one thing knowing that two different plants each have genes conferring specific traits of interest, says Ohalo CEO Dave Friedberg. The problem is that when you crossbreed them, a random 50% of the genes from each parent transfer to their offspring, which means the whole endeavor remains a crapshoot. “[With traditional cross-breeding methods] it may never happen that you get all the good genes together in one plant to make it both disease resistant and drought resistant, for example.”. California-based Ohalo, which has spent the last five years in stealth mode honing its gene editing techniques and filing patents (click here and here), effectively ensures the progeny of two plants will get all the traits of interest by ensuring that both parents pass on their entire genome to their offspring
Vinod Khosla and Dave Friedberg struck a largely positive note on stage at the World Agri-Tech and Future Food-Tech conferences in San Francisco last week despite the ongoing funding winter.While AgFunder reported a 49.2% decline in agrifoodtech funding in 2023 and many startups face the abyss this year without a fresh influx of capital, money is always available for exceptional founders with disruptive products or technologies, insisted Dave Friedberg, CEO at investment group The Production Board (TPB) during a panel debate with Khosla Ventures founder Vinod Khosla last Tuesday.“Exceptional founders have nothing to worry about,” said Friedberg. “But being a founder doesn’t give you the privilege of being able to raise money. And so that’s a fundamental truth that everyone’s going to get hit in the head with at some point. You can’t blame the market.”“That is so true,” agreed Khosla. “There are so many me-too kinds of startups. In fact, what I would argue is what the market has done is separated the really good startups from the not so good… Markets go up and down and you have to roll with the punches.”Vinod Khosla on cultivated meat: ‘We’ve probably looked at two dozen business plans, and not one made economic sense’Khosla, who highlighted his firm’s investments in Nitricity (on-farm nitrogen), Leaft (Rubisco protein), Impossible Foods (plant-based meat), Vertical Oceans (high-tech shrimp farming), Climate Corp (ag data), and Blue River (ag robotics) over the years, said: “I don’t think there are any areas I would say we’ve pulled back from
The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.
San Francisco, CA, USA
$105k - $125k/yr
San Francisco, CA, USA
Find jobs on Simplify and start your career today
Industries
Food & Agriculture
Biotechnology
Company Size
51-200
Company Stage
Late Stage VC
Total Funding
$100M
Headquarters
Seacliff, California
Founded
2019
$80k - $120k/yr
Aptos, CA, USA
San Francisco, CA, USA
$105k - $125k/yr
San Francisco, CA, USA
Find jobs on Simplify and start your career today